206 related articles for article (PubMed ID: 36936374)
61. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
62. Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.
Yin W; Jiang X; Tan J; Xin Z; Zhou Q; Zhan C; Fu X; Wu Z; Guo Y; Jiang Z; Ren C; Tang G
Front Oncol; 2020; 10():1409. PubMed ID: 32974146
[TBL] [Abstract][Full Text] [Related]
63. Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma.
Wang H; Cui J; Yu J; Huang J; Li M
Front Genet; 2022; 13():855940. PubMed ID: 35464865
[TBL] [Abstract][Full Text] [Related]
64. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
[TBL] [Abstract][Full Text] [Related]
65. Integrative Dissection of Novel Lactate Metabolism-Related Signature in the Tumor Immune Microenvironment and Prognostic Prediction in Breast Cancer.
Yang L; Tan P; Sun H; Zeng Z; Pan Y
Front Oncol; 2022; 12():874731. PubMed ID: 35574387
[TBL] [Abstract][Full Text] [Related]
66. A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.
Liu L; Liang L; Mai G; Chen Y
FASEB Bioadv; 2022 Sep; 4(9):585-601. PubMed ID: 36089979
[TBL] [Abstract][Full Text] [Related]
67. Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma.
Guo C; He Y; Chen L; Li Y; Wang Y; Bao Y; Zeng N; Jiang F; Zhou H; Zhang L
Front Oncol; 2022; 12():1030246. PubMed ID: 36439473
[TBL] [Abstract][Full Text] [Related]
68. The prognostic role of fatty acid metabolism-related genes in patients with gastric cancer.
Xu W; Ding H; Zhang M; Liu L; Yin M; Weng Z; Xu C
Transl Cancer Res; 2022 Oct; 11(10):3593-3609. PubMed ID: 36388036
[TBL] [Abstract][Full Text] [Related]
69. THBS1, a fatty acid-related metabolic gene, can promote the development of laryngeal cancer.
Ji FH; Qiu XG
Sci Rep; 2022 Nov; 12(1):18809. PubMed ID: 36335208
[TBL] [Abstract][Full Text] [Related]
70. A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.
Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Zhang ZB; Wang SG; Xia QD
Front Immunol; 2022; 13():908068. PubMed ID: 35898492
[TBL] [Abstract][Full Text] [Related]
71. Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma.
Wang S; Chen A; Zhu W; Feng D; Wei J; Li Q; Shi X; Lv X; Liu M
Front Genet; 2022; 13():905508. PubMed ID: 35910199
[No Abstract] [Full Text] [Related]
72. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
Yang F; Zhou LQ; Yang HW; Wang YJ
Front Genet; 2022; 13():927614. PubMed ID: 36092911
[No Abstract] [Full Text] [Related]
73. Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets.
Wan Q; Liu C; Liu C; Liu W; Wang X; Wang Z
Front Oncol; 2020; 10():585980. PubMed ID: 33324561
[TBL] [Abstract][Full Text] [Related]
74. Identification of a Prognostic Model Based on Fatty Acid Metabolism-Related Genes of Head and Neck Squamous Cell Carcinoma.
Du P; Chai Y; Zong S; Yue J; Xiao H
Front Genet; 2022; 13():888764. PubMed ID: 35846149
[TBL] [Abstract][Full Text] [Related]
75. Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer.
Wang D; Zhang Y; Wang X; Zhang L; Xu S
Front Genet; 2023; 14():1022265. PubMed ID: 36741321
[No Abstract] [Full Text] [Related]
76. Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes.
Ding R; Wei H; Jiang X; Wei L; Deng M; Yuan H
Front Oncol; 2022; 12():1094657. PubMed ID: 36568252
[TBL] [Abstract][Full Text] [Related]
77. Deciphering the expression patterns of homologous recombination-related lncRNAs identifies new molecular subtypes and emerging therapeutic opportunities in epithelial ovarian cancer.
Hua T; Zhang XC; Wang W; Tian YJ; Chen SB
Front Genet; 2022; 13():901424. PubMed ID: 36246624
[TBL] [Abstract][Full Text] [Related]
78. Application of an Autophagy-Related Gene Prognostic Risk Model Based on TCGA Database in Cervical Cancer.
Shi H; Zhong F; Yi X; Shi Z; Ou F; Xu Z; Zuo Y
Front Genet; 2020; 11():616998. PubMed ID: 33633773
[No Abstract] [Full Text] [Related]
79. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
80. Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
Xie F; Bai Y; Yang X; Long J; Mao J; Lin J; Wang D; Song Y; Xun Z; Huang H; Yang X; Zhang L; Mao Y; Sang X; Zhao H
Int Immunopharmacol; 2020 Dec; 89(Pt A):107135. PubMed ID: 33189609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
